Since VEXAS is an autoinflammatory disease with late onset (median age at onset— 64), these results might suggest that the inflammation in these patients could be driven by increased STING signaling due to defective degradation triggered by an increased presence of cytosolic DNA associated with cellular senescence that would lead to increase in IL1β release45–47. This evidence concerns the gene IL1B and VEXAS syndrome.